Cubist Systematic Strategies, LLC Abbott Laboratories Call Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $12.9 Million - $15.3 Million	-129,300 Reduced 95.0%	6,800 $775,000
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $13.3 Million - $14.8 Million	131,900 Added 3140.48%	136,100 $14.1 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $1.38 Million - $1.52 Million	-12,600 Reduced 75.0%	4,200 $477,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $3.58 Million - $4.38 Million	-39,700 Reduced 70.27%	16,800 $1.85 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $4.54 Million - $5.44 Million	-47,500 Reduced 45.67%	56,500 $5.47 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $886,864 - $988,152	-8,800 Reduced 7.8%	104,000 $11.3 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $6.17 Million - $7.26 Million	63,700 Added 129.74%	112,800 $11.4 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $4.6 Million - $5.4 Million	48,400 Added 6914.29%	49,100 $5.39 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $67,732 - $78,421	700 New	700 $68,000

3,185

1.31B

8.74M

7.89M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.